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Ceramides and glucosylceramides are pivotal mol-
ecules in multiple biologic processes such as apopto-
sis, signal transduction, and mitogenesis. In addition,
ceramides are major structural components of the
epidermal permeability barrier. The barrier cera-
mides derive mainly from the enzymatic hydrolysis
of glucosylceramides. Recently, anti-ceramide and
anti-glucosylceramide anti-sera have become avail-
able that react speci®cally with several epidermal
ceramides and glucosylceramides, respectively. Here
we demonstrate the detection of two epidermal
covalently bound w-hydroxy ceramides and one
covalently bound w-hydroxy glucosylceramide spe-
cies by thin-layer chromatography immunostaining.
Moreover, we show the ultrastructural distribution of
ceramides and glucosylceramides in human epider-
mis by immunoelectron microscopy on cryopro-
cessed skin samples. In basal epidermal cells and
dermal ®broblasts ceramide was found: (i) at the
nuclear envelope; (ii) at the inner and outer mito-
chondrial membrane; (iii) at the Golgi apparatus and
the endoplasmic reticulum; and (iv) at the plasma
membrane. The labeling density was highest in
mitochondria and at the inner nuclear membrane,
suggesting an important role for ceramides at these
sites. In the upper epidermis, ceramides were loca-
lized: (i) in lamellar bodies; (ii) in trans-Golgi net-
work-like structures; (iii) at the corni®ed envelope;
and (viii) within the intercellular space of the stratum
corneum, which is in line with the known analytical
data. Glucosylceramides were detected within lamel-
lar bodies and in trans-Golgi network-like structures
of the stratum granulosum. The localization of
glucosylceramides at the corni®ed envelope of the
®rst corneocyte layer provides further proof for
the existence of covalently bound glucosylceramides
in normal human epidermis. Key words: corni®ed
envelope/glycosphingolipids/immunostaining/skin barrier. J
Invest Dermatol 117:1126±1136, 2001
A
mong sphingolipids, outstanding interest has been
dedicated to the biologic functions of ceramides (Cer)
and in the recent past also to those of glucosylcer-
amides (GlcCer). Cer are involved in numerous
cellular signaling processes in response to extracellular
stress, such as apoptosis, terminal differentiation, or cell cycle arrest
and growth suppression (reviewed in Geilen et al, 1997; Perry and
Hannun, 1998). Cer analogs with natural fatty acid chain lengths
(C16±C24) activate several protein kinases (MuÈller et al, 1995;
Huwiler et al, 1996; Zhang et al, 1997), protein phosphatases
(Chalfant et al, 1999), and the protease cathepsin D (Heinrich et al,
1999).
The fate of intracellular Cer has been followed using synthetic
Cer short-chain analogs (C2±C6) (Rosenwald and Pagano, 1993)
or radiolabeled biosynthetic precursors (Van Echten-Deckert et al,
1997), but the sites of Cer compartmentalization are still obscure.
Cer de novo synthesis takes place at the cytoplasmic lea¯et of the
endoplasmic reticulum (ER). The lipid can be further metabolized
to GlcCer at the cytosolic surface of the cis-Golgi cisternae or
converted into sphingomyelin, most probably in the Golgi lumen
(Jeckel et al, 1992). Another source of Cer generation is the
hydrolysis of sphingomyelin at the plasma membrane in response to
extracellular stimuli, such as tumor necrosis factor-a, interleukin-1,
and endotoxin (reviewed in Levade and JaffreÂzou, 1999). Cell
permeable short chain analogs of Cer accumulate in the Golgi
apparatus (Lipsky and Pagano, 1983, 1985), but the various sites of
Cer action also suggest a localization near the plasma membrane
and the mitochondria (Perry and Hannun, 1998).
GlcCer are important intermediates in glycosphingolipid bio-
synthesis and markers for multidrug resistant tumors that express
enhanced GlcCer levels (Lavie et al, 1996; Lucci et al, 1998).
Moreover, they play an essential part in mitogenesis, epidermal
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differentiation, and neuronal growth (reviewed in Ichikawa and
Hirabayashi, 1998); however, enzyme targets for GlcCer have not
yet been identi®ed. As with Cer, the subcellular distribution of
endogenous GlcCer is not yet clear. A part of newly synthesized
GlcCer is translocated from the cytosolic to the luminal site of the
cis-Golgi for further glycosylation; however, a considerable portion
of GlcCer is directly transported to the plasma membrane, where
the main fraction (up to 45%) of cellular GlcCer is found (Klenk
and Choppin, 1970; Jeckel et al, 1992; Warnock et al, 1993).
In the epidermis, Cer and GlcCer play a pivotal role in the
maintenance of the epidermal permeability barrier. This barrier
consists of a compact lipid matrix of Cer, free fatty acids and
cholesterol embedded between the corneocytes in the stratum
corneum (SC). GlcCer are the major precursors of epidermal Cer
(Holleran et al, 1993). Both lipid families are transported to the SC
by specialized secretory organelles, the lamellar bodies (LB). These
are enriched in a polar lipid mixture of GlcCer, phospholipids, and
sterols, and contain several acid hydrolases (Freinkel and Traczyk,
1985). At the transition of the stratum granulosum (SG) into the SC
the LB fuse with the plasma membrane of the uppermost granular
cell and extrude their contents into the intercellular space of the
SC. Concomitantly, the polar lipids are enzymatically cleaved into
the unpolar barrier lipids. The latter are arranged into multiple
intercellular lipid lamellae, forming an ef®cient barrier against
transcutaneous water loss (Elias and Menon, 1991; Forslind et al,
1997).
The epidermis is marked by a unique diversity of Cer and
GlcCer species. To date, eight Cer and six GlcCer classes are
known, the structures of which vary in the degree of hydroxylation
of the sphingosine backbone and of the fatty acid (Fig 1). Among
them there are two Cer and two GlcCer species that contain an w-
hydroxy long chain fatty acid (C28±C34) (Wertz and Downing,
1983; Hamanaka et al, 1989; Robson et al, 1994; Stewart and
Downing, 1999). The Cer with w-hydroxyacyl (w-OH-acyl)
residues are known to be covalently bound to proteins of the
corni®ed envelope of the corneocytes in the SC, thereby
connecting the lipid matrix and the surrounding corneocytes
(Marekov and Steinert, 1998). A corresponding covalently bound
form of w-OH-acyl GlcCer has recently been identi®ed in the
epidermis of mice accumulating these lipids due to a defect in
GlcCer catabolism (Doering et al, 1999a, b). As the amounts of the
corresponding Cer were signi®cantly reduced in these transgenic
mice, it had been proposed that protein-bound GlcCer are at least
in part direct precursors of the protein-bound Cer; however,
protein-bound GlcCer have not yet been identi®ed in normal
human epidermis.
Considering the multiple targets of Cer action and the essential
role of GlcCer and Cer in epidermal homeostasis, it is of increasing
interest to identify the subcellular localization of these lipids at the
ultrastructural level. Recently, speci®c anti-sera against GlcCer and
Cer have become commercially available. First applications of these
sera in immuno¯uorescence staining of human epidermis have been
reported (Brade et al, 2000; Vielhaber et al, 2001), but proof for the
localization of Cer and GlcCer in epidermis by immunoelectron
Figure 1. Structures of epidermal Cer and
GlcCer. According to Robson et al (1994) (Cer-
1±Cer-7), Stewart and Downing, 1999) (Cer 8),
Wertz and Downing (1983) (GlcCer-1±GlcCer-3,
GlcCer-5), and Hamanaka et al (1989) (GlcCer-1,
GlcCer-4). The position of the double bond in
the sphingosine backbone of GlcCer-4 was not
cleared up and is therefore indicated as a dashed
line.
Figure 2. Anti-Cer reacts with two covalently bound epidermal
Cer in TLC immunostaining. Aliquots of a standard lipid mixture
(lane 1), lipids released by base hydrolysis from pre-extracted epidermis
(lane 2) and an epidermal lipid extract (1.0 mg, lane 3) were separated by
TLC and visualized with a spray reagent (TLC) or by immunostaining
with mouse anti-Cer (ITLC), diluted 1 : 25. The standard lipid mixture
was composed of cholesterol (Chol), Cer-1, Cer-2, Cer-3, and Cer-5
(8 nmol lipid each). (A) Cer A; (B) Cer B. The arrow indicates the
origin.
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microscopy is still lacking. Here we show that the anti-sera react
with both free and acylated w-OH-GlcCer and w-OH-Cer,
respectively, and report on the ultrastructural localization of GlcCer
and Cer in normal human epidermis.
MATERIALS AND METHODS
Anti-sera The anti-GlcCer rabbit anti-serum and the IgM-enriched
mouse anti-Cer anti-serum were a gift from GlycoTech Produktions-
und Handelsgesellschaft mbH, Kuekels, Germany.
Lipids Cer-2 (ceramide type III) and Cer-5 (ceramide type IV),
GlcCer-2, cholesterol, N-palmitoyl-D-sphingomyelin, phosphatidyl-
ethanolamine, and phosphatidylserine were purchased from Sigma
(Taufkirchen, Germany). Cer-3 was obtained from Cosmoferm (Delft,
the Netherlands). Cer-1 was chemically synthesized by R.R. Schmidt
(University of Konstanz). Soybean GlcCer was isolated as described
previously (Brade et al, 2000). In the same publication we had
erroneously designated GlcCer-sb as GlcCer-3; however, MALDI-TOF
mass spectrometric analysis (positive ion mode) of GlcCer-sb showed a
major quasimolecular ion of m/z 736.2 [M + Na]+, corresponding to a
GlcCer containing a 2-hydroxypalmitic acid and a 4,8-sphingadienine
backbone, which represents the main GlcCer species in soybean (Sullards
et al, 2000). All substances were dissolved in chloroform/methanol (3:1,
vol/vol).
Isolation of covalently bound lipids Epidermal lipid extracts from
human breast skin were prepared as described by Doering et al (1999a).
For isolation of covalently bound Cer and GlcCer, the residual epidermal
fragments were subjected to a further extraction, washed twice with
100% MeOH at room temperature and incubated in 95% MeOH for 1 h
at 60°C. The pellet was repeatedly washed and incubated in warm
MeOH until the supernatant was free of lipid [as judged from thin-layer
chromatography (TLC) staining] before it was treated with 1 M KOH in
95% MeOH for 2 h at 40°C. Liberated lipids were recovered by two
subsequent extractions of the supernatant.
MALDI-TOF-MS MALDI-TOF-MS of isolated soybean GlcCer
(see Lipids section) and of covalently bound Cer and GlcCer was
performed with a Bruker-Re¯ex III (Bruker-Franzen Analytik, Bremen,
Germany) in linear and re¯ector TOF con®guration at an acceleration
voltage of 20 kV and delayed ion extraction. The compounds were
Figure 3. Anti-GlcCer detects a covalently bound epidermal
GlcCer species in TLC immunostaining. Aliquots of a standard lipid
mixture (lane 1), lipids released by base hydrolysis from pre-extracted
epidermis (0.5 mg, lane 2) and an epidermal lipid extract (1.0 mg, lane 3)
were separated by TLC and visualized with a spray reagent (TLC) or by
immunostaining with rabbit anti-GlcCer (ITLC), diluted 1 : 1000. The
standard lipid mixture was composed of cholesterol (Chol), Cer-2,
GlcCer-2, GlcCer from soybean (GlcCer-sb), sphingomyelin (SM),
phosphatidylethanolamine (PE), and phosphatidylserine (PS) (5 nmol
lipid each). The bracket indicates the covalently bound GlcCer. In
addition to the speci®c staining of GlcCer species, a cross-reaction with
cholesterol occurred due to the high amounts of cholesterol present in
the epidermal extract (lane 3). The arrow indicates the origin.
Figure 4. MALDI-TOF-MS of covalently bound Cer and GlcCer.
Lipids were released from epidermis by alkaline hydrolysis, separated by
TLC and subjected to TLC-immunostaining with anti-Cer (A,B) or
anti-GlcCer (C). The immunoreactive bands were eluted from the silica
gel of a nonstained TLC run in parallel. The indicated molecular masses
represent positively charged sodium adducts of the respective molecules.
The likely compositions of the predominant peaks are indicated with the
carbon chain length of the fatty acid in the ®rst position and that of the
sphingosine base in the second position. The asterisk denotes an
unidenti®ed impurity from the silica gel.
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dissolved in CHCl3/CH3OH (50:50 vol/vol) at a concentration of 1 mg
per ml and vigorously vortexed. One microliter of the sample was then
mixed with 1 ml 0.5 M matrix solution of 2,5-dihydroxybenzoic acid
(gentisic acid, DHB, Aldrich, Steinheim, Germany) in a 2:1 mixture of
0.1% tri¯uoroacetic acid/acetonitrile and aliquots of 0.5 ml were
deposited on a metallic sample holder and dried in a stream of air. The
mass spectra shown are the average of at least 50 single analyses. Mass
scale calibration was performed externally with similar compounds of
known chemical structure.
TLC and TLC immunostaining Lipids were separated twice on silica
gel 60 TLC plates with a solvent system of CHCl3/MeOH/CH3COOH
(190:9:1 vol/vol/vol) and visualized by spraying with 10% CuSO4 and
8% H3PO4 in water and heating at 180°C (Imokawa et al, 1991). For
separation of GlcCer, a third run in CHCl3/MeOH/NH4OH (65:35:5
vol/vol/vol) was performed. TLC immunostaining was performed as
described previously (Brade et al, 2000; Vielhaber et al, 2001). Brie¯y,
the plates were blocked with 0.1% nonfat dry milk/1% polyvinyl
pyrrolidone in washing buffer (50 mM Tris/HCl, pH 7.4, 200 mM
NaCl) and subsequently incubated overnight with rabbit-anti-GlcCer,
diluted 1:1000 in blocking solution. After ®ve washings bound antibody
was detected by incubation with horseradish peroxidase-conjugated goat
anti-rabbit IgG, diluted 1:1000 in blocking solution and following
treatment with a mixture of 4-chloro-1-naphthol and hydrogen peroxide
as the substrate. For immunostaining with anti-Cer the TLC plates were
®rst incubated with 0.1% saponin in washing buffer, blocked with 5%
nonfat dry milk in washing buffer and subsequently incubated with
mouse serum against ceramide (1:25) in blocking solution. After ®ve
washings bound antibody was detected by incubation with horseradish
peroxidase-conjugated goat anti-mouse IgM, diluted 1:1500 in blocking
solution and developed as described for anti-GlcCer.
Skin preparation for immunohistochemistry Normal human skin
biopsies obtained from human forearm were used in this study.
Cryopreparation by high-pressure freezing and freeze substitution was
carried out as described by Pfeiffer et al (2000). Brie¯y, the skin
specimens were placed in the cavity (100 mm in depth) of a standard
aluminum platelet ®lled with 1-hexadecene. The sandwich was inserted
in the specimen holder and frozen in a high-pressure freezer (HPM 010
Bal-Tec, Balzers, FL; MuÈller and Moor, 1984). The subsequent freeze
substitution (at ±90°C for 30 h, ±70°C for 8 h, ±50°C for 8 h) was
performed using acetone as substitution medium and uranyl acetate as
®xing agent in a conventional freeze-substitution unit (FSU 010 Bal-
Tec, Balzers, FL). Before cooling down to ±90°C, the substitution
medium was saturated with uranyl acetate at room temperature. The
specimens were transferred directly to transfer vessels (Hohenberg et al,
1994) and placed in 1.5 ml microfuge tubes (Eppendorf) ®lled with the
substitution medium. After freeze substitution the skin specimens were
in®ltrated with methacrylate (HM20, Polysciences, Eppelheim, Germany)
by the following protocol (at ±50°C). Specimens were washed in pure
acetone for 30 min before in®ltration with 30% (vol/vol) HM20/70%
(vol/vol) acetone, and 70% HM20/30% acetone for 2 h, followed by
three incubations for 2 h each in pure HM20. The ultraviolet
polymerization was carried out at ±50°C for 48 h followed by a
postpolymerization at room temperature for at least 3 d.
Immunohistochemistry The following steps were performed at
room temperature and all dilutions were prepared in washing buffer
(phosphate-buffered saline/0.5% bovine serum albumin/0.2% ®sh
gelatin).
For immuno¯uorescence, semithin sections (200 nm) were placed on
glass coverslips, treated with normal goat serum (3% in phosphate-
buffered saline) for 1 h, washed twice and incubated with anti-GlcCer-3
anti-serum (1:50) or with anti-Cer-anti-serum (1:2) for 1 h.
Subsequently, the sections were washed four times and incubated with a
Cy3-conjugated goat anti-rabbit IgG or goat anti-mouse IgM secondary
antibody (Dianova, Hamburg, Germany) 1:800 for 1 h. The samples
were washed six times, ®xed on slides with MOWIOL and investigated
with a Axioskop 35 ¯uorescence microscope (Zeiss, Jena, Germany).
Image documentation was done with a Kodak Ektachrome 400 ®lm.
Immunogold staining was performed on ultrathin sections (70 nm) as
described for immuno¯uorescence except that the number of washing
steps was doubled. For the double labeling experiments the primary and
secondary antibodies were applied simultaneously. As secondary anti-
bodies a goat anti-rabbit IgG (F(ab¢)2 fragment) conjugated with 10 nm
gold (anti-GlcCer) or a goat anti-mouse IgM (m-chain speci®c) conju-
gated with either 5 nm, 15 nm, or (in the double labeling experiments)
20 nm gold was used (each 1:50). Finally, the sections were poststained
with uranyl acetate and investigated with a TEM912W (LEO,
Oberkochen, Germany). Digital image acquisition was performed with a
CCD camera (ProScan, MuÈnchen, Germany). Image processing and
statistical analysis were performed with the software AnalySIS 2.01 (Soft
Imaging System, MuÈnster, Germany).
RESULTS
Anti-Cer and anti-GlcCer react with very long chain w-OH
epidermal Cer and GlcCer, respectively, in TLC
immunostaining In previous studies it had been demonstrated
that the anti-sera against Cer and GlcCer used here for
immunohistochemistry react with several epidermal Cer and
GlcCer species, respectively, in TLC immunostaining (Brade et al,
2000; Vielhaber et al, 2001). Anti-Cer reacts strongly with Cer-2,
Cer-5, and Cer-6, and to a lesser extent with Cer-1, Cer-3, and
Cer-7 (Fig 2, lanes 1 and 3). A reaction with Cer-4 could not be
detected, probably due to the low amounts of the lipid present in
the epidermal extract. Anti-GlcCer reacts preferentially with
GlcCer from soybean (GlcCer-sb), but also with human
GlcCer-2 and some yet unidenti®ed epidermal GlcCer species
Figure 5. Localization of GlcCer and Cer in
human epidermis by immuno¯uorescence
microscopy. Semithin sections of high-pressure
frozen and freeze-substituted human skin,
embedded in Lowicryl HM20, were stained with
rabbit anti-GlcCer (A) and mouse anti-Cer (B)
and Cy3-conjugated goat anti-rabbit IgG (A) or
Cy3-conjugated goat anti-mouse IgM (B). The
®ne line in (A) indicates the epidermal±dermal
junction. Scale bar: 20 mm.
VOL. 117, NO. 5 NOVEMBER 2001 LOCALIZATION OF (GLUCOSYL-)CERAMIDE IN EPIDERMIS 1129
(Fig 3, lanes 1 and 3); however, the reactivity with very long chain
w-OH-Cer and w-OH-GlcCer that occur ester-linked to proteins
of the corni®ed envelope had not so far been investigated. To
ensure that the anti-sera are able to detect also these lipid species,
the following TLC and ITLC experiments were done.
Human epidermis was subjected to exhaustive lipid extraction
and subsequently treated with alkaline methanol to cleave off ester-
linked lipids (Wertz et al, 1989). The liberated lipids were separated
by TLC in parallel with a mixture of puri®ed lipids and an
untreated epidermal lipid extract and checked for lipid species
reacting with anti-Cer (Fig 2) or anti-GlcCer (Fig 3). Anti-Cer
reacted with two lipids of the fraction released by alkaline
hydrolysis (Fig 2, lane 2), the molecular weight of which
corresponded to the known protein-bound w-OH-Cer species,
Cer A and Cer B, as determined by MALDI-TOF-MS (Fig 4A, B).
In TLC immunostaining with anti-GlcCer one major and one
minor band with Rf values similar to those of GlcCer-2 were
stained in the extract of released covalently bound lipids (Fig 3,
lane 2). The mass spectrometric analysis revealed that both bands
represented a GlcCer with a ceramide portion corresponding to
Cer A with fatty acid chain lengths from C30 up to C37 (Fig 4C);
however, in accordance with Doering et al (1999a, b) we could not
detect a GlcCer with a ceramide portion corresponding to Cer B.
Taken together, with the reaction of the two anti-sera with the
majority of known epidermal Cer and GlcCer species, respectively,
including very long chain w-OH-Cer and w-OH-GlcCer, the
prerequisite for a representative immunohistochemical investiga-
tion on the ultrastructural distribution of Cer and GlcCer in
epidermis was given.
Anti-GlcCer staining concentrates in the SG, whereas anti-
Cer preferentially stains the lower epidermis and the
SC For all immunolight and immunoelectron microscopic
experiments human epidermal samples were high-pressure frozen,
freeze-substituted in acetone and embedded in Lowicryl HM20
(Pfeiffer et al 2000). This preparation method provides an excellent
preservation of the ultrastructure and the proteinaceous antigenicity
as well as an excellent lipid retention (Weibull et al, 1983; Humbel
and MuÈller, 1984; Pfeiffer et al, 2000).
Immuno¯uorescence microscopy showed clearly that the two
anti-sera did not cross-react with the respective heterologous
antigen, as the anti-sera stained different epidermal sites (Fig 5).
Anti-GlcCer stained exclusively the SG and upper SS, with an
intracellular, vesicular pattern except in the uppermost SG where
only the cell boundaries were stained (Fig 5A). No GlcCer were
detected in the SC, in the lower epidermal layers or in the dermis.
Interestingly, the immuno¯uorescence pattern of anti-GlcCer was
nearly identical to that obtained by (O'Guin et al, 1989) with a
monoclonal antibody directed against a protein associated with LB.
In contrast, anti-Cer staining was concentrated at the cell
membranes and/or the intercellular space in the SC and in the
perinuclear region of the cells in the lower stratum spinosum (SS),
the stratum basale (SB) and the dermis (Fig 5B). A faint staining
was also observed at the cell periphery and/or the plasma
membrane of the cells in the viable epidermis.
GlcCer are localized in LB and at the membranes of trans-
Golgi network (TGN)-like structures of the uppermost
granular cells In contrast to Cer, GlcCer were only detected in
LB of the SG and the upper SS in immunoelectron microscopy
(Fig 6, asterisks). In the uppermost layer of the SG, gold particles
were observed within and at the membranes of closely arranged,
large vesicles (Fig 7) that presumably represent TGN compart-
ments. Those structures span a dense network throughout the
cytoplasm of the uppermost SG cells (Elias et al, 1998).
The GlcCer staining was most intense at the transition of the SG
to the SC. Upon fusion of the LB with the plasma membrane of the
uppermost granular cells, GlcCer were found at the corni®ed
envelope (Fig 7, arrowheads) of the cells in the ®rst SC layer, which
appeared as a homogeneous, electron dense layer on the surface of
the corneocytes. In the second SC layer, the staining sharply
Figure 6. GlcCer are localized at the corni®ed envelope of
corneocytes in the lowermost SC layer. Immunogold staining of
GlcCer on ultrathin sections of cryoprocessed human skin, embedded in
HM20. Overview of the SG and the lower SC. GlcCer were found in
LB of the SS (insert) and of the SG (asterisks) as well as in TGN-like
compartments (white arrow). Note the sharp decrease of labeling at the
transition from the ®rst to the second corneocyte layer. Scale bar:
250 nm.
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decreased (Fig 6). No labeling was observed in the higher SC
layers.
In the lower epidermis, Cer is located at membranes of the
ER, the Golgi, the nucleus, mitochondria, and at the plasma
membrane Immunoelectron microscopy with anti-Cer revealed
two separate pools of Cer. One of which was located in the SB and
lower SS where four preferred localizations could be distinguished:
(i) the ER and the Golgi apparatus; (ii) the nuclear envelope; (iii)
the inner and outer mitochondrial membranes; and (iv) the plasma
membrane (Fig 8). In addition, multivesicular bodies occasionally
showed gold particles (data not shown). This staining pattern
disappeared in the more differentiated cells. In the SG, a staining of
the mentioned organelles was found only very rarely. Quantitation
of the number of gold particles per membrane length of the
different organelles in the cells of the SB revealed that the labeling
was most dense on mitochondrial membranes compared with the
nuclear membrane, the ER, the Golgi, and the plasma membrane
with respective ratios of 11.9:4.6:3.6:3.7:1 (Table I). Interestingly,
Cer labeling on the nuclear envelope was preferentially localized to
the inner nuclear membrane with a ratio of 3.0 (n = 35) relative to
the outer nuclear membrane.
For estimation of the inner mitochondrial membrane length we
referred to the work of Schwerzmann et al (1986) who found that
in rat liver mitochondria the areas of the inner mitochondrial
membrane was threefold larger than that of the outer membrane.
The area ratio of the mitochondrial membranes might differ in
epidermal cells; however, even if the ratio of the outer to the inner
membrane area was supposed to be 1:1 (corresponding to a total
mitochondrial membrane labeling density of 11.1 6 0.56 gold
particles per mm) or 1:4 (corresponding to 16.64 6 0.84 gold
particles per mm)±in every case the mitochondria remained the
most densely labeled organelles.
In the upper epidermis, Cer are localized in LB, in the
intercellular space and at the corni®ed envelope The second
pool of Cer was localized in the uppermost layer of the epidermis,
showing gold particles arrayed like a string of pearls along the
corni®ed envelope (Fig 9A) and in the intercellular space of the SC
(Fig 9B, C). As expected, Cer labeling was also localized in the LB
at the interface of the SC and the SG (Fig 9D). Finally, a
prominent labeling was found in all LB upon their nascence in the
SS up to the uppermost SG (Fig 10). In addition, Cer staining in
the SS was found in vesicular organelles and at the plasma
membrane. In the SS and predominantly in the SG Cer was
localized in larger, vesicular structures, which probably represent
TGN compartments (white arrows in Fig 10). LB were often
found in close proximity to TGN-like structures, many of which
were present especially in the uppermost SG layer (Fig 7).
In control experiments without the primary antibodies only
occasionally gold particles were observed that were randomly
distributed over the whole section (data not shown).
DISCUSSION
Cer and GlcCer are important biologic effector molecules. In the
epidermis, they ful®ll an essential role as structural components of
the epidermal permeability barrier. There is a range of data from
biochemical analyses on the distribution of both sphingolipids in
the different epidermal layers, whereas the subcellular compart-
mentalization of Cer and GlcCer has not yet been elucidated in
detail. With the aid of two new anti-sera against Cer and GlcCer,
respectively, and an optimized cryopreparation method for trans-
mission electron microscopy of human epidermis, it became
possible to investigate the subcellular distribution of GlcCer and
Cer in cryoprocessed human epidermis by immunoelectron
microscopy.
In this study we ®rst assured by TLC immunostaining that both
antibodies do not only react with free epidermal Cer and GlcCer,
but also with very long chain w-OH-Cer and w-OH-GlcCer
liberated from the epidermis by alkaline hydrolysis. Thus, the
prerequisite for a representative immunohistochemical study on the
subcellular distribution of Cer and GlcCer was given. Using
immuno¯uorescence and immunoelectron microscopy we showed
that Cer are localized in dermal and basal epidermal cells in
mitochondria, at the nuclear envelope, at the plasma membrane, at
the ER, and at the Golgi complex. In the upper epidermis, Cer
were found in LB, in the intercellular space of the SC, and at the
corni®ed envelope of the corneocytes. GlcCer were exclusively
Figure 7. GlcCer is secreted to the SG/SC interface via LB that derive from TGN-like compartments. Immunogold staining of GlcCer on
ultrathin sections of cryoprocessed human skin, embedded in HM20. Cell at the SG/SC transition. GlcCer is transported from TGN-like
compartments (white arrows) via LB to the plasma membrane of the uppermost granular cells. Note the staining of the corni®ed envelope (arrowheads).
Scale bar: 250 nm.
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detected in LB and at the corni®ed envelope of the lowermost
corneocytes.
The immuno¯uorescence staining patterns obtained with anti-
Cer and anti-GlcCer generally showed a good correlation with the
known lipid analytical data; however, there was a lack of GlcCer
staining in the lower epidermis. The Cer and GlcCer content of
human epidermis changes from 4% (Cer)/3.5% (GlcCer) of the
total lipid weight in the basal and spinous layers and 9%/6% in the
granular layer to 25%/traces in the SC (Lampe et al, 1983). On a
molar weight basis, the Cer content exceeds that of GlcCer 2-fold
in the SB/SS, 2.5-fold in the SG, and 31-fold in the SC. Thus, the
cellular amounts of the named sphingolipids in the lower epidermis
might be suf®cient for the detection of Cer, but not for that of
GlcCer. A high local concentration of such a small antigen is a
prerequisite for its detection in immunohistochemistry, and in the
case of GlcCer, this is presumably only given in the LB.
The immunoelectron microscopic investigation revealed a
concentration of Cer in the mitochondria of basal epidermal and
dermal cells, suggesting an important role for Cer in these
organelles. This hypothesis is supported by the growing evidence
for a participation of ceramide in the regulation of mitochondrial
function (Ghafourifar et al, 1999; Di Paola et al, 2000) and the
recent identi®cation of a mitochondrial ceramidase (El Bawab et al,
2000). Moreover, the presence of Cer in mitochondria correlates
with previous observations made by Lipsky and Pagano (1983),
who incubated Chinese hamster ®broblasts with liposomes con-
taining the ¯uorescent Cer-analog C6-NBD-Cer at 2°C. They
detected 90% of the ¯uorescent lipid within mitochondria, whereas
the residual 10% were found at the nuclear envelope and the ER.
Upon warming up the cells to 37°C, the ¯uorescence rapidly
associated with the Golgi complex, where C6-NBD-Cer was
further metabolized to glycosphingolipid analogs.
In addition, a signi®cant portion of cellular ceramide was
found at the nuclear envelope, obviously re¯ecting the
biosynthetic site of Cer at the ER; however, statistical analysis
revealed that Cer were preferentially localized at the inner
nuclear membrane. The presence of a nuclear pool of Cer
provides support for previous assumptions of an involvement of
Cer in apoptotical events occurring at or in the nucleus.
Recently, increased neutral sphingomyelinase and ceramidase
activities have been measured in puri®ed nuclei from rat
hepatocytes after induction of apoptosis by portal vein branch
Figure 8. Ultrastructural localization of Cer
in basal human epidermal cells. Immunogold
staining of Cer on ultrathin sections of
cryoprocessed human skin, embedded in HM20.
Cer staining (15 nm gold) was found preferentially
(A) at the nuclear membrane (B) on the ER and
(C) Golgi membranes, and (D) in mitochondria.
g, Golgi apparatus; m, mitochondrion; n, nucleus;
arrowheads, nuclear membrane; arrows, plasma
membrane. Scale bar: 500 nm.
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ligation in the liver (Tsugane et al, 1999). It had been suggested
that Cer are generated at the inner lea¯et of the nuclear
envelope (Hoekstra, 1999). In this context, it is interesting to
note that the proteinaceous apoptotic inhibitor bcl-2 is localized
in the same compartments as Cer with the exception of the
Golgi apparatus and the plasma membrane (Akao et al, 1994).
Figure 9. Ultrastructural localization of Cer
in the upper epidermis. Immunogold staining
of Cer on ultrathin sections of cryoprocessed
human skin, embedded in HM20. (A)Corneocytes
were stained along the corni®ed envelope (15 nm
gold). (B)If the intercellular space of the SC was
free of biological material, Cer (5 nm gold) were
concentrated on the corneocytes surface. (C)Cer
staining (5 nm gold) was found mainly
intercellularly, if the intercellular space was ®lled
with biological material. (D)LB (arrows) at the SG/
SC transition zone were labeled with anti-Cer
(5 nm gold). Scale bar: (A) 1 mm; (B±D) 200 nm.
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The second main Cer fraction was located in the upper
epidermis, where Cer were found in all LB from their nascence
in the mid to upper SS up to the uppermost SG and at the corni®ed
envelope, indicating that Cer are incorporated into LB upon their
biogenesis. Interestingly, in contrast to the prominent labeling of
the TGN-like compartments, neither Cer nor GlcCer labeling was
found in the Golgi apparatus of the upper SS and the SG,
underlining the functional distinctness of the Golgi and the TGN in
the upper epidermis (Man et al, 1995; Elias et al, 1998). Together
with the accumulation of NBD-Cer in the TGN of the outermost
SG cell layer in three-dimensional organotypic cultures (Elias et al,
1998) and the lack of Cer labeling at the nuclear membrane and in
mitochondria in the upper epidermal cell layers, these data suggest
that the activity of Cer metabolism in the differentiated epidermis is
concentrated to the TGN and LB.
In the SC, Cer labeling was concentrated at the corni®ed
envelope, whereas labeling of the intercellular space was only
rarely detected; however, mechanical stress during removal of
the punch itself and of the skin biopsy from the punch often
causes widening of the intercellular space in the SC, leading to
large intercellular areas of up to 1 mm in the mid and upper SC
(Fig 9A). These areas were free of biological material, and the
lipids were concentrated near the corneocyte surface. In regions
where the intercellular space is ®lled with biologic material,
especially in the lower SC, we detected Cer mainly
intercellularly (Fig 9C).
Intercellular membranes in the SC, however, were not
detectable in the labeled sections. From our experience, the
multiple incubation steps during immunolabeling resulted in a
blurring of the lipid lamellae structure. This is caused by a loss
of the contrasting agent uranyl acetate during exposure of the
section surface to the aqueous solutions as uranyl acetate does
not covalently bind but only associates to the skin lipids.
Therefore, we shortened the immunolabeling protocol to a
minimum (about 4 h in total still gave a good signal-to-
background ratio). Nevertheless, whereas uranyl acetate is
extracted, the lipids are retained in the section and can be
visualized by immunolabeling.
Finally, it is important to note that precise Cer and GlcCer
immunohistochemical localization can only be performed with
specimens dehydrated at temperatures below ±50°C and
embedded into Lowicryl resins with subsequent ultraviolet
light polymerization at ±50°C to minimize the loss of lipids
(Weibull et al, 1983), as already stated in preceding publications
(Brade et al, 2000; Vielhaber et al in press). With the use of
uranyl acetate as the sole ®xative during freeze substitution the
extraction of lipids is further reduced (Humbel and MuÈller,
1984; Pfeiffer et al, 2000).
Our ®nding of a GlcCer labeling in closely arranged, large
vesicles that probably represent TGN compartments correlates
well with previous investigations: Elias et al (1998) demonstrated
Figure 10. Cer are transported to the SC via LB. Immunogold
staining of Cer (15 nm gold) on ultrathin sections of cryoprocessed
human skin, embedded in HM20. Cer were predominantly localized in
LB (arrows) in the SS and the SG, but also at the plasma membrane and
in vesicular organelles (white arrows). In their close proximity LB were
often observed. Note that the number of LB continuously increases with
ongoing epidermal differentiation. Scale bar: 500 nm.
Table I. Labeling densities of ceramide in organelles of
basal epidermal cellsa
Compartment
Labeling density (gold
particles/membrane length)
Nuclear envelope 5.66 6 0.32/mm (n = 39)
Plasma membrane 1.24 6 0.18/mm (n = 20)
ER 4.44 6 0.49/mm (n = 16)
Golgi 4.57 6 0.45/mm (n = 10)
Mitochondriab (outer + inner membrane) 14.71 6 0.77/mm (n = 89)
Nucleoplasm (background) 0.46 6 0.13/mm (n = 16)
aThe membrane length was determined with the aid of the analySIS software at
a magni®cation of 328,000. The values of labeling density are expressed as the
mean value 6 SEM. The number of compartments counted is given in brackets.
The number of gold particles (15 nm) counted was 1743.
bThe length of the inner mitochondrial membrane (mi) was calculated on the ba-
sis of the assumption that the area of mi is about 3-fold larger than the area of mo
(Schwerzmann et al, 1986). Thus, the length of mi corresponds to Ö3 *mo.
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that the uppermost granular cells are ®lled up with TGN
membranes, appearing as a tubuloreticular structure. The latter
could be labeled with the Golgi-speci®c ¯uorescent Cer analog
NBD-Cer. In addition, Madison and Howard, 1996) showed by
NBD-Cer labeling that in differentiated keratinocyte cultures
Cer are transported through the Golgi apparatus, where they
are further metabolized into GlcCer and transported to the
plasma membrane by a vesicular mechanism. Later, the same
group provided additional evidence for a Golgi origin of LB via
the correlation of increasing ceramide glucosyltransferase activity
with differentiation, GlcCer amount, and LB formation
(Madison et al, 1998).
The immunoelectron microscopical investigations with anti-
GlcCer demonstrated that GlcCer are secreted via LB into the
intercellular space of the SC and then associate with the
corni®ed envelope of the cells in the ®rst corneocyte layer.
Together with the detection of a covalently bound GlcCer
species by TLC immunostaining and in agreement with studies
in transgenic mice (Doering et al, 1999a, >b), our data support
the signi®cance of these unique glycoconjugates as precursors
for protein-bound Cer.
The concentration of endogenous Cer in mitochondria and at
the nuclear envelope demands further investigations into the
role of endogenous Cer at these sites. The combination of
biochemical analyses and Cer immunoelectron microscopy will
provide a powerful tool to elucidate further the relationship of
Cer with the various signal transduction pathways. Finally, it
will be of special interest for dermatologists to analyze the
ultrastructural distribution of GlcCer and, in particular, Cer in
pathologic epidermis with a disturbed barrier function as, for
example, in atopic dry skin or ichthyotic skin.
We thank N. Harmel for excellent technical assistance, O. Brandt for providing
samples of human skin, and H. Brade, G. Grif®ths, and T. Doering for critically
reading the manuscript.
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